SCHEDULE: Capital Research Global Investors Discloses Stake in Blue Owl Capital

Capital Research Global Investors has reported a beneficial ownership of 8.7% in Blue Owl Capital Inc. as of March 31, 2026.

Summary

• Capital Research Global Investors (CRGI) has filed a Schedule 13G, indicating their beneficial ownership of Blue Owl Capital Inc. common stock.
• CRGI holds 58,075,965 shares, representing 8.7% of the outstanding shares.
• This ownership stake was reported as of March 31, 2026.
• CRGI is a division of Capital Research and Management Company (CRMC) and its affiliates, which collectively provide investment management services.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it confirms a significant, stable investment by a major asset manager, indicating confidence without providing new operational or financial performance data.

Positives

• Significant ownership stake of 8.7% by a major investment manager, Capital Research Global Investors, suggests confidence in Blue Owl Capital's prospects.
• The filing confirms that the shares are held in the ordinary course of business, implying a stable, long-term investment approach rather than a hostile takeover attempt.

Risks

• The filing does not explicitly mention any risks. However, any investment in public equities carries inherent market risks.
• As a significant shareholder, CRGI's investment decisions could influence market perception and stock price volatility.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Blue Owl Capital Inc. It is a disclosure of ownership by an investment entity.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by Capital Research Global Investors, a significant asset manager, indicates a substantial institutional investment in Blue Owl Capital Inc. Such filings often signal a degree of confidence in the company's strategy and financial performance by large, sophisticated investors.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which can be viewed positively as it may lend stability and credibility to the stock.
• Management: The certification by Capital Research Global Investors that the shares are held in the ordinary course of business suggests they are not seeking to influence control, which can be reassuring for current management.
• Market Analysts: This filing provides data for analysts to assess the ownership structure and potential influence of major shareholders.

Next Steps

• Monitor future filings from Capital Research Global Investors for any changes in their stake.
• Observe Blue Owl Capital Inc.'s performance and strategic announcements for insights into the continued appeal of its stock to institutional investors.

Key Dates

Keywords

Blue Owl Capital, Capital Research Global Investors, Schedule 13G, Beneficial Ownership, Investment Management, SEC Filing, Common Stock, Institutional Investor